Unraveling the Financial and Strategic Position of WST Post Q1 2024 Results
West Pharmaceutical Services ( NYSE:WST ) First Quarter 2024 Results Key Financial Results Revenue: US$695.4m (down...
Despite a dip in Q1 performance, West Pharmaceutical projects a robust year with strategic expansions and improved guidance.